搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Managed Healthcare Executive
3 天
Another Trial of Winrevair Stopped Early Due to Positive Efficacy
The HYPERION study was evaluating Winrevair in recently diagnosed adults with pulmonary arterial hypertension.
BioWorld
9 天
Lysosomes, NCOA7 on the scene of pulmonary arterial hypertension
Researchers from the University of Pittsburgh School of Medicine have linked pulmonary arterial hypertension (PAH), a ...
3 天
Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in ...
TX45 improved both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with ...
pulmonologyadvisor
11 天
Exercise Pulmonary Hypertension Independently Predicts Survival in Some Patients
Exercise PH — measured by the mPAP/CO slope — may predict survival in patients with normal or mildly elevated pulmonary arterial pressure.
Daily
9 天
Persistent Pulmonary Hypertension may not increase postoperative complications in Patients ...
Recent research paper titled "Impact of Persistent Pulmonary Hypertension of the Newborn in Neonates with ...
Daily
2 天
Merck to stop trial evaluating Winrevair early in pulmonary arterial hypertension
Rahway: Merck, known as MSD outside of the United States and Canada, has announced the Phase 3 HYPERION study evaluating ...
BioWorld
3 天
CF Pharmtech describes new prodrugs of treprostinil
CF Pharmtech Guangzhou Ltd. and CF Pharmtech Hongkong Ltd. have identified prodrugs of treprostinil reported to be useful for the treatment of pulmonary hypertension and pulmonary fibrosis.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈